Mon 13 Jul 2009 | 0:25 EDT

You are here: Home > News > Article

Do More With Reuters

Partner Services

Affiliate Network

Professional Products

Support (Customer Zone)

Financial Products

About Thomson Reuters

OXiGENE begins pivotal registration study for Zybrestat in anaplastic thyroid cancer

Mon Jul 9, 2007 2:00pm EDT

Email | Print |

Share

| Reprints | Single Page

[-] Text [+]

Co announces it has begun a pivotal registration study of its first-in-class vascular disrupting agent, Zybrestat (combretastatin-A4 phosphate / CA4P), in patients with metastatic anaplastic thyroid cancer.

© Thomson Reuters 2009 All rights reserved

Share:

Also on Reuters

Flashes of lighting illuminate the sky during a thunderstorm over Shanghai, July 12, 2009. REUTERS/Aly Song

U.S. officials to prod China on climate change

Restaurant patrons try to catch sight of US President Barack Obama and first lady Michelle Obama leaving the theater during a personal visit for dinner and a Broadway play in New York, May 30, 2009. REUTERS/Jonathan Ernst

Black culture lights up Broadway's Great White Way

Sacha Baron Cohen as "Bruno" caught upside down on a wire during his entrance at the 2009 MTV Movie Awards in Los Angeles, May 31, 2009. REUTERS/Mario Anzuoni

"Bruno" fashions top spot at U.S. box office

More InPlay Briefing.com

Insight Enterprises' board authorizes additional $50 mln stock repurchase

Ampex and Hillside agree to 60 day extension to standstillaAgreement; engages Commercial Strategy to pursue licensing efforts

New Oriental reports Q2 EPS of $0.07 vs $0.10 in 2Q07; revs rose 129% to $18.2 mln - no ests

General Steel reports Q3 EPS of $0.25 vs $0.20 two analyst est; revs rose $636% YoY to $345.4 mln vs $289.86 mln two analyst est

Ansoft beats by $0.01, reports revs in-line

More InPlay Briefing.com News...

Editor's Choice

Soldiers salute during a repatriation ceremony for Master Corporal Pat Audet and Corporal Martin Joannette at Canadian Forces Base Trenton in Trenton, Ontario July 9, 2009. REUTERS/Blair Gable

A selection of our best photos from the past 24 hours. Slideshow

Most Popular on Reuters

Articles
Video

Most Popular Articles RSS Feed

We want to hear from you

Join the Reuters Consumer Insight Panel and help us get to know you better

Join the Reuters Consumer Insight Panel and help us get to know you better

Please take a moment to complete our survey

Reuters.com: Help and Contact Us | Advertise With Us | Mobile | Newsletters | RSS | Labs | Archive | Site Index | Video Index

Thomson Reuters Corporate: Copyright | Disclaimer | Privacy | Professional Products | Professional Products Support | About Thomson Reuters | Careers

International Editions: Africa | Arabic | Argentina | Brazil | Canada | China | France | Germany | India | Italy | Japan | Latin America | Mexico | Russia | Spain | United Kingdom | United States

Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.

NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.